Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Biolen (bicalutamide implant)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Alessa Therap
Drug class:
Androgen receptor antagonist
Related drugs:
‹
apalutamide (9)
nilutamide (4)
GT0918 (3)
BMS-641988 (2)
EPI-7386 (2)
HC-1119 (1)
TAK 700 (1)
IONIS-AR-2.5Rx (0)
sulforafan alfadex (0)
TAS3681 (0)
TQB3720 (0)
TRC253 (0)
cyproterone acetate (0)
TOK-001 (0)
EPI-506 (0)
INO-464 (0)
apalutamide (9)
nilutamide (4)
GT0918 (3)
BMS-641988 (2)
EPI-7386 (2)
HC-1119 (1)
TAK 700 (1)
IONIS-AR-2.5Rx (0)
sulforafan alfadex (0)
TAS3681 (0)
TQB3720 (0)
TRC253 (0)
cyproterone acetate (0)
TOK-001 (0)
EPI-506 (0)
INO-464 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
SNAI2 deletion
Prostate Cancer
SNAI2 deletion
Prostate Cancer
abiraterone acetate + degarelix + bicalutamide implant
Sensitive: C3 – Early Trials
abiraterone acetate + degarelix + bicalutamide implant
Sensitive
:
C3
abiraterone acetate + degarelix + bicalutamide implant
Sensitive: C3 – Early Trials
abiraterone acetate + degarelix + bicalutamide implant
Sensitive
:
C3
BRCA2 A902fs*2
Prostate Cancer
BRCA2 A902fs*2
Prostate Cancer
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant: C4 – Case Studies
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant
:
C4
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant: C4 – Case Studies
abiraterone acetate + bicalutamide implant + leuprorelin depot
Resistant
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login